The effectiveness of group cognitive behavior therapy on drug compliance, quality of life and anxiety in patients with bipolar mood disorder

Clinical trial of the effectiveness of group cognitive behavior therapy on improving drug compliance, quality of life and decreasing anxiety in female patients with bipolar mood disorder type I

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201112108359N1

Enrollment

Registered

2013-07-14

Start date

2013-10-12

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar affective disorder. Bipolar affective disorder

Interventions

Intervention 1: Intervention group: First, the pre-test will be done. The experimental group will participate in 12 sessions of cognitive group therapy managed by the researcher. During the sessions,

Treatment - Other

Intervention group: First, the pre-test will be done. The experimental group will participate in 12 sessions of cognitive group therapy managed by the researcher. During the sessions, the researcher w

Control group: This group will not receive any intervention. Both of the groups will receive drug therapy. The difference of the quality of life, anxiety and drug compliance of the pre-test and the po

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Women patients with bipolar mood disorder type I hospitalized in women ward, being in the age range 20 to 40, having at least high school degree in education, not being in acute phase of illness, being in relative recovery phase of disorder and lack of brain injuries, mental retardation, substance abuse and epilepsy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Anxiety. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Zung Self-Rating Anxiety Scale.;Quality of life. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Quality of life questionnaire (SF36).;Drug compliance. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Health Belief Model questionnaire.	—

Measure

Time frame

Anxiety. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Zung Self-Rating Anxiety Scale.;Quality of life. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Quality of life questionnaire (SF36).;Drug compliance. Timepoint: Before intervention, after intervention and every mount until 3 mounts. Method of measurement: Health Belief Model questionnaire.

—

Secondary

Measure	Time frame
Age. Timepoint: Pre-test. Method of measurement: Personal-social questionnaire.;Marital status. Timepoint: Pre-test. Method of measurement: Personal-social questionnaire.;Illness duration. Timepoint: Pre-test. Method of measurement: Personal-social questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Rahmani

Razi hospital of Tabriz University of Medical Sciences

frahmani@tbzmed.ac.ir+98 41138044869

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026